Board Meeting Intimation for Intimation Of The Board Meeting
FREDUN PHARMACEUTICALS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2018 ,inter alias, to consider and approve the allotment of 6,18,500 Equity Shares. Shareholding for the Period Ended June 30, 2018
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Daulat MedhoraDesignation :- Director Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Voting Results Of Postal Ballot
In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the business transacted by the Postal Ballot of the Company, along with the Scrutinizers Report issued by M/s. Rajendra R. Vaze, Practising Company Secretaries. Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the year ended March 31, 2018; as approved by the Board in its Meeting held on Monday, June 18, 2018; published in Free-press Journal & Navshakti on Wednesday, June 20, 2018. Outcome Of The Board Meeting
In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule III of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (the 'Company'), at its Meeting held on Monday, June 18, 2018; have considered and approved the Financial Results for the year ended March 31, 2018. Board recommends Final Dividend
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2018, inter alia, have considered and approved the following:- Recommended Final Dividend @ 6% i.e., Rs. 0.60/- per Equity Share having face value of Rs. 10/- each for the Financial Year 2017-18; subject to the Approval of the Shareholders at the ensuing Annual General Meeting of the Company. Board Meeting-Outcome of Board Meeting
In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule 111 of SEBl Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (the 'Company'), at its Meeting held on Monday, June 18, 2018; have considered and approved the Audited Financials for the year ended March 31, 2018.